Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
By Deena Beasley (Reuters) - Upcoming data from a mid-stage study of Amgen (NASDAQ:AMGN)'s experimental weight-loss drug MariTide will shed light on how well it might measure up...